
    
      Interventional, Multicentric, Randomized Controlled Study in Two Parallel Groups of 530
      Healthcare Professionals working in the Intensive Care Unit Exposed to Risk of COVID19
      Infection Taking Hydroxychloroquine (HCQ) (200 mg/day) VS Placebo
    
  